SGRY · XBRL financial data

Surgery Partners financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (SGRY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
General and administrative	97	104	102	121	139	118
Total operating expenses	1,677	1,923	2,194	2,415	2,766	2,919
Operating income (loss)	183	302	345	328	349	390
Other income (expense)	—	(0)	2	9	—	—
Income tax expense (benefit)	(20)	11	23	(0)	135	18
Net income (loss)	(116)	(71)	(55)	(12)	(168)	(78)
Earnings per share, basic USD per share	(3.19)	(1.12)	(0.59)	(0.09)	(1.33)	(0.61)
Earnings per share, diluted USD per share	(3.19)	(1.12)	(0.59)	(0.09)	(1.33)	(0.61)
Weighted average shares, basic millions of shares	49	72	92	126	126	127
Weighted average shares, diluted millions of shares	49	72	92	126	126	127

Fiscal years (SGRY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	318	390	283	196	270	240
Accounts receivable	382	430	456	496	579	602
Inventory	56	61	71	75	88	97
Total current assets	802	946	921	895	1,119	1,151
Right-of-use asset	310	324	279	255	296	289
Goodwill	3,468	3,912	4,137	4,326	5,068	5,195
Total assets	5,413	6,118	6,682	6,877	7,890	8,120
Accounts payable	100	125	152	172	209	209
Total current liabilities	557	537	493	523	624	616
Lease liability, non-current	301	316	271	249	292	280
Accumulated deficit	(432)	(503)	(557)	(569)	(737)	(815)
Total stockholders' equity	116	1,089	1,998	1,987	1,790	1,713
Total liabilities and equity	5,413	6,118	6,682	6,877	7,890	8,120
Common shares outstanding (cover page) millions of shares	60	89	126	127	128	129

Fiscal years (SGRY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(116)	(71)	(55)	(12)	(168)	(78)
Stock-based compensation	13	17	18	18	33	15
Depreciation and amortization	95	99	115	118	153	176
Net cash from operating activities	247	87	159	294	300	274
Purchases of property and equipment	43	58	81	89	90	79
Net cash from investing activities	(88)	(332)	(308)	(226)	(489)	(247)
Proceeds from issuing common stock	0	582	883	0	0	—
Share repurchases	0	—	—	—	—	—
Proceeds from long-term debt	429	299	218	827	1,730	1,203
Repayments of long-term debt	216	343	862	807	1,279	1,040
Net cash from financing activities	67	316	42	(155)	262	(57)
Net change in cash	225	72	(107)	(87)	74	(30)

SIC 8062 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8062 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Surgery Partners	217	not reported	59*	130.9M	Q2 FY26 10-QJun 30, 2026
Select Medical Holdings	26	1,421	38	124.0M	Q1 FY26 10-QMar 31, 2026
Pediatrix Medical Group	312	501	117*	78.1M	Q3 FY26 10-QSep 30, 2026
Universal Health Services	139	4,638	443*	not reported	Q2 FY26 10-QJun 30, 2026
Tenet Healthcare	2,674	5,631	1,281*	79.6M	Q3 FY26 10-QSep 30, 2026
Encompass Health	76	1,610	362*	98.1M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.